Switch to:

Provider tip: use Magellan Rx website to submit preauth requests for IVIG, SCIG and Remicade products


ConnectiCare has contracted with Magellan Rx Management (Magellan Rx) to manage the review of preauthorization requests for the following specialty drugs for both our commercial and Medicare Advantage plans:

  • Intravenous Immunoglobulin (IVIG)
  • Subcutaneous Immunoglobulin (SCIG)
  • Remicade® (infliximab)
  • All Remicade’s biosimilar products 

To help you submit preauthorization requests, Magellan Rx’s secure website at (registration and log in required) is available 24 hours a day, seven days a week. The website will guide you through submitting the information needed for the review. Here are highlights of other features available through the Magellan Rx website.